Broadview Ventures

Broadview is a mission-driven fund whose primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. We define success – return on a mission – as improving human health by bringing innovative technologies to patients. INVESTMENT CRITERIA Our primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. Indication – Broadview invests in cardiovascular, metabolic, and neurovascular disease We define cardiovascular broadly to include: - Heart Disease - Peripheral Vascular Disease - Valvular Disorders - Hypertension and Cardio-Renal - Underlying pathways (e.g., inflammation, atherogenesis) We are interested in metabolic disease as it relates to cardiovascular risk factors, including: - Obesity - Type II diabetes - Metabolic syndrome - Dislipidemia - Stroke is the primary indication within the neurovascular focus Technology – Diversified across therapeutics, devices, diagnostics, and regenerative therapies Stage – Our preferred stage of investment is Seed to Series A, typically late pre-clinical through clinical proof-of-concept